Georgia BioEd Institute Announces Renewed Funding to Support Life Science Education

Georgia BioEd Institute announced renewed funding today that supports STEM education in school systems across Georgia that will provide teachers with the training and equipment they need to better prepare students for the Georgia workforce.

For the second year, Georgia BioEd has been given funding for the Rural Teacher Training Initiative (RTTI) to provide training on laboratory experiences for teachers in rural areas. To further enrich STEM classes, the Georgia BioEd Institute works with local industries to support the Equipment Depot, which is a ground-breaking program that provides donated lab supplies to enhance STEM education in Georgia’s classrooms. The Equipment Depot, the only one of its kind on the East Coast, has recently expanded to provide even more STEM support to Georgia’s teachers. In its first year, these programs provided training to 72 teachers from 23 schools across the state, impacted 11,500 students, and accepted close to $200,000 in industry equipment donations for classrooms.

With almost 2500 square feet, the Equipment Depot is large enough to accept and store more donated equipment and easily allow educators to reserve and pick up equipment to utilize in their classrooms. In addition, RTTI will continue to help strengthen Georgia’s life science workforce pipeline through proven teacher trainings and equipment support. In fact, during this challenging time, Georgia BioEd has also been able to offer virtual alternatives for labs to ensure students still get the best quality education during the pandemic.

“The life science industry is $21 billion and growing in the state of Georgia,” says Maria Thacker-Goethe, CEO of Georgia Bio. “If we want to be a leader in life sciences then we need to start in our schools, and this means we need to equip our teachers with the right tools to successfully teach STEM. Our goal is to our expand our community of STEM educators and strengthen our industry.”

Lack of equipment is one of the top reasons stated by teachers as a barrier to perform more STEM labs with their students in Georgia schools. The Equipment Depot solves this challenge by collecting lightly used, last generation, and surplus equipment, supplies, and consumables from industry. The Georgia BioEd Institute gets them into the schools for use in STEM labs. A bonus is that these donations also help the environment, keeping thousands of pounds of equipment out of landfills. In the last 12 months, the Equipment Depot has processed almost 4,000 pounds of donations.

“A signature aspect of our training is that we provide equipment to all participants, not just for the training, but also to use in the classroom to implement lessons with students,” said Georgia BioEd Institute Director, Kristin Boscan. “After all, it’s the students who are our future workforce. We need to get the skills, concepts, and inspiration to  them. This funding is a win for STEM education.”

Continued funding from the Department of Education to the program partner, the Georgia Youth Science & Technology Centers (GYSTC), will advance the RTTI program. Georgia BioEd expresses our gratitude to the following state legislative leadership for helping to make this valuable initiative real to the benefit of all Georgians: Governor Brian Kemp, Lt. Governor Geoff Duncan, House Appropriations Chairman Terry England, Senate Appropriations Chairman Blake Tillery, House Appropriations Education Subcommittee Chairman Robert Dickey, Senate Appropriations Education Subcommittee Chairman Ellis Black, Senate Agriculture Chairman John Wilkinson, and House Ethics Chairman Randy Nix. We want to especially thank the late Jack Hill, former Senate Appropriations Chairman.

To learn more about Georgia BioEd Institute, RTTI, tour the Equipment Depot, and where to donate, please visit  https://gabio.org/georgia-bioed/. All are invited to attend the  virtual Grand Opening of the Equipment Depot , Wednesday, September 16th, 4:30 – 5:30 p.m.

Georgia Life Sciences Designates City of Atlanta as Newest BioReady® Community

By Sheran Brown • February 21, 2025
Georgia Life Sciences Designates City of Atlanta as Newest BioReady® Community

Bipartisan PBM Reform Back in Focus as House Committee Plans Hearing

By Sheran Brown • February 20, 2025
A renewed push for prescription drug cost reform is gaining momentum in Congress, with the House Energy and Commerce Committee's health subcommittee planning a hearing on pharmacy benefit manager (PBM) reform for late February. The hearing, to be led by Rep. Buddy Carter (R-Ga.), signals a revival of bipartisan efforts to regulate these pharmaceutical intermediaries. PBMs, which negotiate drug prices for insurers and employers, have become a focal point in the broader discussion of healthcare costs. A previous bipartisan agreement to regulate these entities was crafted by Carter and Rep. Diana DeGette (D-Colo.) in the last Congress, though it ultimately stalled when the larger spending bill it was attached to faced opposition. The reform efforts enjoy broad support from both parties and the president, making it one of the few areas with potential for bipartisan cooperation. However, new complications have emerged as Republicans consider using PBM regulations to generate savings for their broader policy agenda, potentially requiring up to $880 billion in cost reductions. The path forward remains uncertain, with ongoing debates about whether such reforms would qualify for budget reconciliation and whether using PBM regulations as a funding mechanism could derail bipartisan cooperation. Meanwhile, stakeholders continue to disagree on the impact of additional PBM regulation, with pharmaceutical companies arguing that PBMs inflate drug costs while PBMs contend that new regulations would increase prices.

Council on State Biotechnology Associations says NIH funds are a critical component of innovation ecosystem

By Sheran Brown • February 20, 2025
The Council of State Biotechnology Associations (CSBA) has issued a strong warning about proposed cuts to National Institutes of Health (NIH) funding, emphasizing the critical role these grants play in America's biotech innovation ecosystem. The statement, below , comes amid concerns over recent guidance that would reduce NIH funding to key research institutions. ----------------------- “Today, the US biotech industry employs nearly 2.3 million people across the US and is making positive contributions to economic impact and national security across all 50 states. In fact, for every dollar the National Institutes of Health (NIH) contributes to a successful drug, the private sector invests over $65, underscoring the agency’s unparalleled return on investment. As the associations representing the bioscience industry across the nation, the Council on State Biotechnology Associations (CSBA) is concerned by recent guidance that would cut funding provided by the NIH to universities, hospitals, and other institutions that perform critical early-stage research. NIH grant funds are a critical component of our innovation ecosystem. Grants for basic research are the spark that leads to university-driven discoveries, with public-private partnerships and tech transfers that bridge early-stage research to industry-sponsored drug development and ultimately to FDA approved medical advances for hundreds of diseases. While the administration looks for greater efficiency in the use of taxpayer dollars, it cannot be overstated - once scientific innovation moves abroad, it may never return. In the race for scientific innovation around the world, as our adversaries continue to increase government investments in research, we encourage President Trump to follow suit and ensure that we maintain our global leadership in an industry that was created and thrives across the US.”
MORE POSTS
Share by: